Visual Performance Differences Between Clareon PanOptix and a Comparable Multifocal Intraocular Lens
Argus Research Center, Inc.
Summary
This is a two-part, multi-center, investigator-initiated clinical study comparing visual outcomes and patient satisfaction in subjects receiving bilateral implantation of either the Clareon PanOptix intraocular lens (IOL) or a comparable multifocal IOL. The study includes a retrospective/prospective pilot phase and a prospective, randomized comparison phase.
Eligibility
- Age range
- Not specified
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: Stage 1: IIT Pilot * Willing and able to understand and sign informed consent. * Adult patients previously diagnosed with age-related cataracts bilaterally. * Previous bilateral age-related cataract removal and with bilateral implantation of the Clareon PanOptix/ Clareon PanOptix Toric (T3-T4) or Comparable Multifocal Intraocular Lens (equivalent to T3-T4) closest to 2.5-5-months after implantation and \>2 weeks post YAG (if done) that were targeted for emmetropia. * Best monocular corrected distance visual acuity was expected to be 0.1 logMAR (Snellen 20/25) or better in…
Interventions
- DeviceClareon PanOptix or PanOptix Toric IOLs
Bilateral implantation of the Clareon PanOptix or PanOptix Toric IOLs.
- DeviceComparable multifocal IOL
Bilateral implantation of a comparable multifocal IOL
Locations (3)
- Wolstan & Goldberg Eye AssociatesTorrance, California
- Tyson EyeCape Coral, Florida
- North Georgia Eye AssociatesGainesville, Georgia